Stoke Therapeutics grants inducement stock options for 53,175 shares at USD 28.15 each
STOK•Inducement stock options granted to new employees
Stoke Therapeutics granted stock options covering 53,175 shares to nine new employees, effective Sept. 15, 2026.
- Exercise price: $28.15 per share, matching the stock’s closing price on Sept. 15, 2026.
- Vesting: 25% after one year, then monthly over the next 36 months.
- Term: 10 years.
- The awards were issued under the 2023 Inducement Plan.
